BELLEVILLE, ON, Nov. 6 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. , a research-based, technology-driven Canadian biopharmaceutical company, today announced that Cameron Groome, Executive Vice-President, Corporate & Strategic Development, will present at the Rodman & Renshaw 9th Annual Global Healthcare Conference in New York City tomorrow. Mr. Groome will present at 8:30 a.m. (Eastern Time) in the Holmes II Room of the New York Palace Hotel.
A live webcast of Bioniche’s presentation can be accessed at http://www.wsw.com/webcast/rrshq12/bnc.to. A replay of the presentation will be archived for 90 days after the conference. For more information about the Rodman & Renshaw 9th Annual Healthcare Conference, please visit http://www.rodmanandrenshaw.com/conferences?id=6.
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development, manufacturing, and marketing of proprietary products for human and animal health markets worldwide. The fully-integrated company employs approximately 198 skilled personnel and has three operating divisions: Human Health, Animal Health, and Food Safety. The Company’s primary goal is to develop proprietary cancer therapies supported by revenues from marketed products in human and animal health. For more information, please visit www.Bioniche.com.
Except for historical information, this news release may contain forward-looking statements that reflect the Company’s current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cause, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, the impact of competitive products and pricing, new product development, uncertainties related to the regulatory approval process, and other risks detailed from time to time in the Company’s ongoing quarterly and annual reporting.
CONTACT: Jennifer Shea, Corporate Communications & Investor, Relations
Manager, Bioniche Life Sciences Inc., Telephone: (613) 966-8058, Cell:
(613) 391-2097, Jennifer.Shea@Bioniche.com
